跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
recombinant fusion protein
首页
药物
recombinant fusion protein
recombinant fusion protein
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
RESPIRATORY SYNCYTIAL VIRUS RECOMBINANT FUSION PROTEIN WITH PRE-FUSION CONFORMATION, PREPARATION METHOD AND USES THEREOF
US 20250222095 A1
申请人: BEIJING BENEWILL TECH DEVELOPMENT CO LTD
优先权: 2022
CN
EP
US
WO
5 件公开
US 20250223321 A1
申请人: BEIJING BENEWILL TECH DEVELOPMENT CO LTD
优先权: 2022
CN
EP
US
WO
5 件公开
RECOMBINANT FUSION PROTEIN FOR ANTIGEN DELIVERY AND USES THEREOF
EP 4563591 A4
申请人: LG CHEMICAL LTD
优先权: 2022
CN
EP
US
WO
4 件公开
RECOMBINANT OPCML FUSION PROTEIN OPTIMIZING OPCML D1 DOMAIN HOMODIMERISATION AND METHODS OF USE FOR CANCER TREATMENT
EP 4608857 A1
申请人: PAPYRUS THERAPEUTICS INC
优先权: 2022
CN
EP
US
WO
4 件公开
RECOMBINANT FUSION PROTEIN TARGETING PD-L1 AND VEGF, AND PREPARATION AND USE THEREOF
EP 4534564 A4
申请人: IMMUNEONCO BIOPHARMACEUTICALS SHANGHAI INC
优先权: 2022
CN
EP
WO
4 件公开
RECOMBINANT FUSION PROTEIN VACCINE CONTAINING CLOSTRIDIOIDES DIFFICILE FLIC AND FLID
US 2024261383 A1
申请人: UNIV SOUTH FLORIDA
优先权: 2023
US
WO
4 件公开
Process for production of a recombinant protein and a fusion protein
US 7276355 B2
申请人: MARINE BIOTECH INST CO LTD
优先权: 2000
US
4 件公开
Recombinant fusion protein and polynucleotide construct for immunotoxin production
US 8043621 B2
申请人: UNIV RAMOT
优先权: 2008
US
4 件公开
US 8597655 B2
申请人: BARNEA ITAY
优先权: 2011
US
2 件公开
RECOMBINANT FUSION PROTEIN FOR TREATMENT OF PULMONARY HYPERTENSION
EP 4713372 A1
申请人: IMMUNECARE BIOPHARMACEUTICALS SHANGHAI CO LTD
优先权: 2023
CN
EP
WO
3 件公开
RECOMBINANT PTH FUSION PROTEIN, CONSTRUCTION METHOD THEREFOR, AND APPLICATION THEREOF
EP 4763868 A1
申请人: KANGZHONG GUANGDONG INC
优先权: 2024
CN
EP
WO
3 件公开
RECOMBINANT FUSION PROTEIN TARGETING CD40 AND CD47
US 20250109212 A1
申请人: BIOSION INC
优先权: 2022
CN
US
3 件公开
第 1 / 10 页
上一页
下一页
药物
反馈